Onconetix Inc (ONCO)

[crudeoil24]

CINCINNATI, April 11, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced that Brian Price, Ph.D., Head of Technology Strategy, will deliver a presentation during the World Vaccine Congress 2022 in Washington, DC. BWV will present on its universal influenza vaccine candidate, which utilizes the exclusively licensed epitopes of limited variability identified by scientists at The University of Oxford.

Session details are as follows:

Date: Wednesday, April 20, 2022

Time: 5:55 p.m. Eastern Daylight Time (EDT)

Title: BWV-101 - Universal Influenza Vaccine Program

BWV Participant: Brian Price, Ph.D., Head of Technology Strategy

“We are honored to present at such a prestigious conference focused on the development of novel vaccines,” said Joseph Hernandez, Chief Executive Officer of Blue Water Vaccines. “In collaboration with The University of Oxford, we are committed to exploring the development of a universal influenza vaccine via epitopes of limited variability and are excited to present our technology to peers from around the world.”

BWV management will be available during the events for one-on-one meetings. Interested parties may request a one-on-one meeting at [e-mail] or contact BWV at [phone].